Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve We hereby inform you that the ....
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 14th November 2025. The main agenda is to consider and approve the Unaudited Financial Results for the quarter ended 30th September 2025 (Q2 FY26), along with the Limited Review Report from the auditors. The filing was signed by Chairman & Whole-Time Director Haresh Kapurlal Mehta on 6th November 2025. No other specific business items were disclosed beyond the standard 'any other matter with the Chair's permission' clause.
This is a routine advance notice ahead of Q2 FY26 earnings. Investors should watch for the actual results announcement post 14th November for the company's quarterly performance, revenue trends, and profitability. Typically such filings do not impact the stock price directly, but the actual numbers released after the meeting may.